Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Classement en actions #42724
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$264.00
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CN
Échange Biostar Pharmaceuticals, Inc. (BSPM)

Catégorie

Le prix BSPM avec la capitalisation boursière de B
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
BSPM
$0.0001
Capitalisation boursière de Biostar Pharmaceuticals, Inc.(BSPM)
Capitalisation boursière: $264.00
En August 2026, Biostar Pharmaceuticals, Inc. a une capitalisation boursière de $264.00. Cela fait de Biostar Pharmaceuticals, Inc. la 42724th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Biostar Pharmaceuticals, Inc. du 2008 au 2026
BSPM par rapport au top 5 des plus populaires stocks
Prix pour BSPM L’actif B La capitalisation boursière de B Résultats
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$2,055,299 $264.00
$5.426T +2,055,298,683,037.50%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,676,862 $264.00
$4.427T +1,676,862,110,490.91%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,567,784 $264.00
$4.139T +1,567,783,913,254.17%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,384,865 $264.00
$3.656T +1,384,865,033,698.11%
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.
$1,093,048 $264.00
$2.886T +1,093,047,674,331.82%